|
Post by marriott on May 10, 2021 13:41:34 GMT
So Reuters News declares " Novavax Inc expected to post a loss of $3.60 a share - Earnings Preview " at today's call .
Considering that Novavax does not currently sell vaccines at market , Reuters headline is neither bold nor thoughtful .
So should Novavax deal with such a declaration, present a confident and clear roadmap to the market that impacts expectations .
|
|